J. E. Davis, the CEO and President of $DGX, sold 2,493 shares of the company on 04-02-2025 for an estimated $422,736. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of their shares of this class of stock. Following this trade, they now own 132,072 shares of this class of $DGX stock.
$DGX Insider Trading Activity
$DGX insiders have traded $DGX stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 7 sales selling 41,447 shares for an estimated $6,843,173.
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 6 sales selling 41,513 shares for an estimated $6,819,095.
- J. E. DAVIS (CEO and President) has made 0 purchases and 15 sales selling 39,191 shares for an estimated $6,602,074.
- MICHAEL J DEPPE (SVP, Corp. Controller & CAO) has made 0 purchases and 6 sales selling 18,755 shares for an estimated $2,889,122.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 2 sales selling 4,330 shares for an estimated $712,875.
- VICKY B GREGG sold 1,250 shares for an estimated $205,710
- MARK E DELANEY (SVP & Chief Commercial Officer) sold 403 shares for an estimated $66,214
- PATRICK PLEWMAN (SVP for Diagnostic Services) sold 320 shares for an estimated $54,307
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DGX Hedge Fund Activity
We have seen 366 institutional investors add shares of $DGX stock to their portfolio, and 348 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,637,525 shares (+42.5%) to their portfolio in Q4 2024, for an estimated $247,037,021
- JPMORGAN CHASE & CO added 916,898 shares (+60.4%) to their portfolio in Q4 2024, for an estimated $138,323,232
- AMERICAN CENTURY COMPANIES INC removed 764,962 shares (-33.4%) from their portfolio in Q4 2024, for an estimated $115,402,167
- CITADEL ADVISORS LLC removed 748,133 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $112,863,344
- UBS GROUP AG added 588,478 shares (+156.3%) to their portfolio in Q4 2024, for an estimated $88,777,791
- WELLINGTON MANAGEMENT GROUP LLP removed 549,280 shares (-23.5%) from their portfolio in Q4 2024, for an estimated $82,864,380
- ALLIANCEBERNSTEIN L.P. added 497,995 shares (+83.7%) to their portfolio in Q4 2024, for an estimated $75,127,525
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DGX Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 7 analysts offer price targets for $DGX in the last 6 months, with a median target of $180.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $180.0 on 02/03/2025
- David MacDonald from Truist Financial set a target price of $182.0 on 01/31/2025
- Eric Coldwell from Robert W. Baird set a target price of $189.0 on 01/31/2025
- Patrick Donnelly from Citigroup set a target price of $185.0 on 10/23/2024
- Michael Cherny from Leerink Partners set a target price of $165.0 on 10/23/2024
- Stephanie Davis from Barclays set a target price of $168.0 on 10/23/2024
- Paige Meyer from CFRA set a target price of $178.0 on 10/22/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
